Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 204.45 K152.68 K113.42 K118.56 K183.2 K577.06 K 992.24 K Research & development —————— — Operating income -204.45 K-152.68 K-113.42 K-118.56 K-183.2 K-577.06 K -992.24 K Non-Operating Income, Total 1.19 M1.59 M1.61 M1.51 M1.38 M1.4 M 5.91 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.19 M1.59 M1.61 M1.51 M1.38 M1.4 M 5.91 M Unusual income/expense —————— — Pretax income 981.03 K1.44 M1.5 M1.39 M1.2 M823.39 K 4.91 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 981.03 K1.44 M1.5 M1.39 M1.2 M823.39 K 4.91 M Discontinued operations —————— — Net income 981.03 K1.44 M1.5 M1.39 M1.2 M823.39 K 4.91 M Dilution adjustment 964.03 K1.59 M1.61 M12.68 M0— — Preferred dividends 964.03 K1.59 M1.61 M12.68 M1.38 M— — Diluted net income available to common stockholders 981.03 K1.44 M1.5 M1.39 M-183.2 K823.39 K 3.53 M Basic earnings per share (Basic EPS) 0.120.140.140.120.10.08 0.44 Diluted earnings per share (Diluted EPS) 0.120.140.140.120.10.08 0.44 Average basic shares outstanding 16.43 M19.04 M19.91 M20.29 M21.61 M21.61 M — Diluted shares outstanding 16.43 M19.04 M19.91 M20.29 M21.61 M21.61 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —